US Stock MarketDetailed Quotes
AIMD Ainos
- 0.5520
- +0.0677+13.98%
Close Oct 2 16:00 ET
- 0.5520
- 0.00000.00%
Post 20:01 ET
4.44MMarket Cap-171P/E (TTM)
0.5625High0.4800Low1.69MVolume0.4850Open0.4843Pre Close891.86KTurnover65.36%Turnover RatioLossP/E (Static)8.05MShares4.289952wk High0.21P/B1.43MFloat Cap0.451052wk Low--Dividend TTM2.59MShs Float356.2500Historical High--Div YieldTTM17.04%Amplitude0.4510Historical Low0.5270Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Ainos Stock Forum
Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA
Ainos, Inc. (NASDAQ:AIMD) has received Institutional Review Board (IRB) approval from the National Taiwan University Hospital for its clinical trial on VELDONA®, a low-dose oral interferon formulation for treating oral warts in HIV-positive patients. The trial, involving 40 participants, will evaluate VELDONA®'...
Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options
Prior Phase 3 studies showed positive benefits in increasing unstimulated whole saliva secretion
Ainos aims to complete all regulatory approvals for the study in Q4 2024
SAN DIEGO, CA / ACCESSWIRE / September 23, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on ...
Accesswire· 3 mins ago
AI Nose now has a 79% accuracy in identifying 761 samples across 22 VOCs in Japanese semiconductor manufacturing factories
AI Nose can be integrated into robotics systems in smart factories, serving as the digital nose of AI technology
No comment yet